Mineralys Therapeutics, Inc.'s lorundrostat shows promise for treating aldosterone-driven hypertension with FDA approval by ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Only a handful of biotechs have completed IPOs this year, headed by Mineralys’ $192 million raise and Structure Therapeutics’ $161 million listing in February, with Genelux and Cadrenal ...

Mineralys looks odds on to become the first drug developer to bring an aldosterone synthase inhibitor to market for uncontrolled hypertension.

Get the detailed quarterly/annual income statement for ABIVAX Société Anonyme (ABVX). Find out the revenue, expenses and profit or loss over the last fiscal year.

Explore Checkpoint Therapeutics Inc OM NEW stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for CKPT. Sun Pharma to acquire Checkpoint Therapeutics for $4.10 ...

Find out all the key statistics for Zymeworks Inc. (ZYME), including valuation measures, fiscal year financial statistics, trading record, share statistics and more.